Pfizer Acquires OTC Company in China
Pfizer has acquired Sirio Pharma Co. Ltd.'s wholly owned subsidiary, Treerly Health Co., Ltd., and its family of Treerly products. Treerly is a healthcare brand in China's retail channel and consists of a portfolio of products designed to meet women's nutritional healthcare needs. Sirio Pharma is a privately held contract manufacturing company in China that produces dietary supplements and drugs. Sirio is currently a qualified third-party supplier to Pfizer Consumer Healthcare. Under the terms of the agreement, Sirio will continue to supply the Treerly family of products to Pfizer Consumer Healthcare.
The acquisition of the Treerly brand and its family of products will enhance the portfolio of dietary supplements we offer to our retail customers in China and will enable us to help more consumers improve their health and well-being,” said Keith Choy, regional president, Asia Pacific, Pfizer Consumer Healthcare. “The addition of the Treerly products will also make it possible to leverage our existing sales and marketing capabilities and be more efficient in launching future innovations for consumers in China,” he said.